SlideShare a Scribd company logo
1 of 7
Download to read offline
8 February 2020 For private circulation only
DAILY DERIVATIVE REPORT 10 FEB 2020
Nifty Futures View Volatility BankNifty Future View
Nifty Active Futures 12095.9 India VIX Index 13.74 BankNifty Active Futures 31240.00
Nifty Active Futures OI 13771200 Nifty ATM Call IV 8.6 BankNifty Active Futures OI 11,57,580
Change in OI 21450 Nifty ATM Put IV 14.74 Change in OI 36160
Premium / Discount -2.45 PCR Index Options 1.40 Premium / Discount 38.00
Inference Short Build up PCR F&O Total 0.92 Inference
Short
Build up
NNiiffttyy OOppttiioonnss OOII DDiissttrriibbuuttiioonn HIGHLIGHTS:
Nifty futures closed at 12095.9 on a negative note with 0.16%
increase in open interest indicating Short Build Up.
Nifty Futures closed at a discount of -2 points compared to
previous day discount of -2 points.
BankNifty closed at 31240 on a negative note with 3.22%
increase in open interest indication Short Build Up.
BankNifty Futures closed at a premium of 38 points compared
to the previous day premium of 29 points.
FII's were Sellers in Index Futures to the tune of 428 crores
and were Buyers in Index Options to the tune of 1025 crores,
Stock Futures were Buyers to the tune of 273 crores. FII's
were Net Buyers in derivative segment to the tune of 869
crores.
India VIX index is at 13.74. Nifty ATM call option IV is currently
at 8.60 whereas Nifty ATM put option IV is quoting at 14.74.
NNiiffttyy OOppttiioonnss --CChhaannggee iinn OOII
Index options PCR is at 1.40 and F&O Total PCR is at 0.92.
Among stock futures IDEA ,DIVISLAB ,APOLLOHOSP & SRF
have witnessed long build up and may show strength in
coming session.
Stock which witnessed short build up are MRF
,GODREJCP ,KOTAKBANK & DLF and may remain weak
in coming session.
Nifty Put options OI distribution shows that 12000 has highest
OI concentration followed by 11500 & 11600 which may act as
support for current expiry.
Nifty Call strike 12500 followed by 12400 witnessed significant
OI concentration and may act as resistance for current expiry.
SSEECCUURRIITTIIEESS IINN BBAANN PPEERRIIOODD::
__________________________________________________________________________________________________________________
SSttoocckk FFuuttuurreess -- LLoonngg BBuuiilldd
____________________________________________________________________________________________________________
SSttoocckk FFuuttuurreess -- SShhoorrtt BBuuiilldd UUpp
Symbol Fut Price % Chg Open Interest % Chg
IDEA 5.30 1.92% 473536000.00 9.37%
DIVISLAB 2074.70 2.25% 1770000.00 8.80%
APOLLOHOSP 1669.45 1.26% 1811500.00 8.47%
SRF 4098.30 2.23% 896250.00 6.32%
Symbol Fut Price % Chg
Open
Interest
% Chg
MRF 70962.80 -1.22% 21570.00 9.55%
GODREJCP 649.65 -0.76% 6480000.00 8.36%
KOTAKBANK 1660.20 -1.21% 8858800.00 6.95%
DLF 235.65 -4.27% 34409100.00 6.37%
WEEKLY DERIVATIVE REPORT
Week ended 7th Feb 2020
NNIIFFTTYY HHIIGGHHLLIIGGHHTTSS::
 Nifty Futures has increased by 3.78% to close at 12,095 from previous week close of 11,655.
 Nifty annualized volatility index India Vix has decreased to 13.75% from 16.83% down by 18.34%.
 The total open interest (OI) in the Nifty stood at Rs 8,345cr.Where as stock futures OI is at 47,148cr.
 The open interest position of FII in Index Futures is at Rs 14,616Cr and in Stock futures is at Rs
104,140Cr.
Nifty PCR OI  PCR OI has made a high of 1.48 & low of
0.86 and closed on weekly basis at 1.40
levels.
 PCR OI currently is at 1.40 levels which is
well above the median line indicating that we
might see some cautiousness in Nifty from
higher levels.
OOppeenn IInntteerreesstt AAnnaallyyssiiss
 Options Built up Shows that for now
nifty has strong support at 12,000
followed by 11,500 and resistance at
12,400 levels followed by 12,500.
 12,400 & 12,500 strike call and 12,200 put
followed by 11,500 put has highest open
interest concentration which suggests
that Nifty is likely to trade between this
levels.
CChhaannggee iinn OOppeenn IInntteerreesstt
 This week major addition was seen on the Put
front with 11,900 and 11,600 strikes adding
10.71 and 13.00 lakh in OI respectively.
 On the Call front we have seen addition at
12,400 strike with increase in OI of 7.34 lakh
shares and an increase of 8.35 lakh shares at
12,500 strike.
0.80
1.00
1.20
1.40
1.60
1.80
2.00
3.00
4.00
5.00
6.00
7.00
8.00
28-Jan
29-Jan
30-Jan
31-Jan
1-Feb
3-Feb
4-Feb
5-Feb
6-Feb
7-Feb
PUTCALLRATIO
OIincr.
Call OI Put OI
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
11500
11600
11700
11800
11900
12000
12100
12200
12300
12400
12500
12600
12700
OpenInterest
Open Interest Put OI Call OI
-1,000,000
-500,000
0
500,000
1,000,000
1,500,000
11500
11600
11700
11800
11900
12000
12100
12200
12300
12400
12500
12600
12700
OpenInterest
Change in Open Interest Call OI Put OI
WEEKLY DERIVATIVE REPORT
VVoollaattiilliittyy AAnnaallyyssiiss
 IV differential between call and put has
increased from last week level, which implies
that nifty is most likely to trade cautious
from the current levels, however the bias
might be positive.
 Call IV’s currently at 11.53%, while Put IV’s are
at 13.57%.
 Implied Volatility of option for the current series is
at 12.54% and has seen downward trajectory in
this week.
WWeeeekkllyy PPaarrttiicciippaanntt WWiissee OOppeenn IInntteerreesstt
Participant
FUT IDX
Long
(contracts)
Net Chg
FUT IDX
Short
(contracts)
Net Chg
Client 182,190 51,721 81,128 15,911
DII 29,224 -11,225 18,451 4,995
FII 29,974 7,408 142,484 18,555
Pro 17,319 -4,064 16,644 4,379
Participant
FUT STK
Long
(contracts)
Net Chg
FUT STK
Short
(contracts)
Net
Chg
Client 792,088 16,456 235,916 82,778
DII 37,225 12,869 1,043,075 -11,611
FII 976,653 80,587 605,927 33,812
Pro 172,525 23,314 93,573 28,247
FFIIII IInnddeexx FFuuttuurreess
 FII activity in the index futures had been mostly
on the Buy side during this week.
 FII have been net Buyer in Index future to the
tune of 557 crore during this week.
FFIIII SSttoocckk FFuuttuurreess
 FII activity in Stock futures had been on the Buy
side during the last week.
 This week FII have been net Buyers in stock future
segment to the tune 3812 crore.
8.50
10.50
12.50
14.50
16.50
18.50
20.50
22.50
28-Jan-
20
29-Jan-
20
30-Jan-
20
31-Jan-
20
1-Feb-
20
3-Feb-
20
4-Feb-
20
5-Feb-
20
6-Feb-
20
7-Feb-
20
Implied volatility(IV) IV Call
Iv Put Historic volatility
160,000
165,000
170,000
175,000
180,000
185,000
190,000
03-Feb 04-Feb 05-Feb 06-Feb 07-Feb
-600
-400
-200
0
200
400
600
800
InCrores
NET AMT OI IN CONTRACT
1,510,000
1,520,000
1,530,000
1,540,000
1,550,000
1,560,000
1,570,000
1,580,000
1,590,000
03-Feb 04-Feb 05-Feb 06-Feb 07-Feb
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
InCrores
NET AMT OI IN CONTRACT
WEEKLY DERIVATIVE REPORT
SSeeccttoorr WWiissee OOppeenn IInntteerreesstt AAnndd PPrriiccee DDaattaa
WWeeeekkllyy PPrriiccee CChhaannggee WWeeeekkllyy OOII CChhaannggee WWeeeekkllyy PPCCRR CChhaannggee
WWeeeekkllyy OOppeenn IInntteerreesstt GGaaiinneerr WWeeeekkllyy OOppeenn IInntteerreesstt LLoosseerr
Script ID Price % Chg OI Futures % Chg
MANAPPURAM 167.6 -11.09% 35076000 90.98%
AMBUJACEM 210.5 2.38% 31827500 76.82%
HEROMOTOCO 2383.05 -2.97% 3442600 70.54%
APOLLOTYRE 164.7 -1.26% 14313000 44.27%
CHOLAFIN 340.7 3.97% 6497500 42.49%
Script ID Price % Chg OI Futures % Chg
MFSL 481.35 -5.05% 5153200 -40.26%
IOC 117.25 4.87% 54520000 -29.37%
JUBLFOOD 1905.35 1.32% 2483500 -18.13%
TORNTPHARM 2025.65 4.98% 341500 -17.21%
RBLBANK 339.35 6.43% 14268000 -14.97%
WWeeeekkllyy PPrriiccee GGaaiinneerr WWeeeekkllyy PPrriiccee LLoosseerr
Script ID Price % Chg OI Futures % Chg
SRTRANSFIN 1210.45 17.92% 5176200 8.69%
AUROPHARMA 546.75 13.57% 14781000 -2.39%
L&TFH 132 12.87% 28806400 -8.52%
JINDALSTEL 198.65 12.58% 33265000 6.50%
JSWSTEEL 279.85 11.07% 62157500 7.56%
Script ID Price % Chg OI Futures % Chg
MANAPPURAM 167.6 -11.09% 35076000 90.98%
ITC 214.2 -9.41% 141525600 10.99%
DLF 235.65 -9.37% 34409100 11.21%
EXIDEIND 182.4 -7.62% 11327400 9.23%
ZEEL 250.5 -7.12% 29557900 22.99%
1.18%
6.00%
0.79%
-9.23%
1.34%
6.86%
1.33%
0.73%
2.91%
-5.13%
0.88%
3.44%
4.47%
3.32%
-1.69%
6.36%
2.44%
2.02%
-1.39%
Wkly Price change
Textile
Fertilisers
Oil_Gas
Cement
Capital_Good
s
Media
FMCG
Pharma
Automobile
Infrastructure
Finance
Others
Power
Metals
Technology
Realty
Banking
Telecom
Index
22.09%
12.80%
4.58%
0.80%
7.67%
14.41%
18.94%
9.79%
9.48%
1.25%
12.30%
5.82%
10.24%
13.59%
4.01%
15.35%
2.61%
17.17%
19.71%
Wkly OI change
Textile
Fertilisers
Oil_Gas
Cement
Capital_Good
s
Media
FMCG
Pharma
Automobile
Infrastructure
Finance
Others
Power
Metals
Technology
Realty
Banking
Telecom
Index
1.11%
0.33%
1.76%
1.54%
1.32%
2.27%
1.48%
1.30%
1.72%
0.98%
1.41%
1.52%
1.17%
0.45%
1.77%
6.87%
1.87%
0.30%
0.66%
Wkly Roll Over change
Textile
Fertilisers
Oil_Gas
Cement
Capital_Good
s
Media
FMCG
Pharma
Automobile
Infrastructure
Finance
Others
Power
Metals
Technology
Realty
Banking
Telecom
Index
WEEKLY DERIVATIVE REPORT
SSttoocckk wwiissee OOppeenn IInntteerreesstt DDiissttrriibbuuttiioonn iinn BBaannkkiinngg SSeeccttoorr
BBaannkk NNiiffttyy OOppeenn IInntteerreesstt ffoorr PPSSUU BBaannkkss VV//ss PPrriivvaattee BBaannkkss
BBaannkk NNiiffttyy SSttrriikkee wwiissee ooppeenn iinntteerreesstt ddiissttrriibbuuttiioonn
RBLBANK, HDFCBANK and ICICIBANK can see some POSITIVE move in this week.
Bank Nifty has a very strong support at 31,000, as 31,000 PE strike is having highest OI concentration
followed by 30,500 and on the Call front 32,000 CE strike has highest OI concentration indicating strong
resistance level followed by 31,500.
AXISBANK BANKBARODA
CANBK
FEDERALBNK
HDFCBANK
ICICIBANK
IDFCFIRSTB
INDUSINDBKKOTAKBANK
PNB, 11%
RBLBANK
SBIN, 10%
YESBANK
29%
71%
Open Interest
Psu Bank Private Bank
0
50,000
100,000
150,000
200,000
250,000
300,000
30200
30300
30400
30500
30600
30700
30800
30900
31000
31100
31200
31300
31400
31500
31600
31700
31800
31900
32000
32100
32200
OpenInterest
Open Interest Call OI Put OI
WEEKLY DERIVATIVE REPORT
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the
Regulations).
1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as
defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution
of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s
largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking,
Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities
and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a
corporate agent for insurance business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research
report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was,
is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does
not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial
ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research
Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial
ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its
associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12-
month period.
Research Team
Sr. No Name Designation E-mail
1 Rajesh Palviya Technical & DerivativeAnalyst - (Head) rajesh.palviya@axissecurities.in
2 Vaishnavi Jagtap Technical Analyst vaishnavi.jagtap@axissecurities.in
3 Hemang Gor Derivative Analyst hemang.gor@axissecurities.in
4 Rahil.vora Derivative Analyst Rahil.vora@axissecurities.in
5 Hiren Trivedi Research Associate hiren.trivedi@axissecurities.in
6 Kiran Gawle Associate kiran.gawle@axissecurities.in
5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market
making activity for the subject company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report,
ASL or any of its associates may have:
i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the
subject company of this research report and / or;
ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or;
iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services
from the subject company of this research report;
ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other
third-party in connection with this report
Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information
contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any
other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and
information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The
information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently
verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such
information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not
constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat
recipients as customers by virtue of their receiving this report.
WEEKLY DERIVATIVE REPORT
Disclaimer:
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable
or appropriate to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report
may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial
positions and needs of specific recipient.
This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should
make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies
referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of
such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade
securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any
responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this
report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs,
reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily
a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in
the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not
predictions and may be subject to change without notice.
ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell
the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or
other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any
recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each
other. The recipient should take this into account before interpreting this document.
ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a
result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this
report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service
transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in
this report.
Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed,
directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is
inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of
the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located
in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law,
regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein
may or may not be eligible for sale in all jurisdictions or to certain category of investors.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be
treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this
document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company
may or may not subscribe to all the views expressed therein.
Copyright in this document vests with Axis Securities Limited.
Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI – INZ000161633, ARN No. 64610, CDSL-IN-DP-CDSL-693-2013, SEBI-
Research Analyst Reg. No. INH 000000297, SEBI Portfolio Manager Reg. No.- INP000000654, Main/Dealing off.- Unit No. 2, Phoenix Market
City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. – 18002100808, Reg. off.- Axis House, 8th Floor, Wadia
International Centre, Pandurang Budhkar Marg, Worli, Mumbai – 400 025.Compliance Officer: Anand Shaha, E-Mail ID:
compliance.officer@axisdirect.in,Tel No: 022-42671582.

More Related Content

What's hot

What's hot (20)

Weekly Derivatives Report :14 October 2019
Weekly Derivatives Report :14 October 2019Weekly Derivatives Report :14 October 2019
Weekly Derivatives Report :14 October 2019
 
Weekly Derivatives Report :07 October 2019
Weekly Derivatives Report :07 October 2019Weekly Derivatives Report :07 October 2019
Weekly Derivatives Report :07 October 2019
 
Equity daily report_ 21 aug 2018
Equity daily report_ 21 aug 2018Equity daily report_ 21 aug 2018
Equity daily report_ 21 aug 2018
 
Weekly Derivatives Report :19 June 2019
Weekly Derivatives Report :19 June 2019Weekly Derivatives Report :19 June 2019
Weekly Derivatives Report :19 June 2019
 
Weekly Derivatives Report :16 September 2019
Weekly Derivatives Report :16 September 2019Weekly Derivatives Report :16 September 2019
Weekly Derivatives Report :16 September 2019
 
Weekly Derivatives Report :16 December 2019
Weekly Derivatives Report :16 December 2019Weekly Derivatives Report :16 December 2019
Weekly Derivatives Report :16 December 2019
 
Weekly Derivatives Report :09 December 2019
Weekly Derivatives Report :09 December 2019Weekly Derivatives Report :09 December 2019
Weekly Derivatives Report :09 December 2019
 
Weekly Derivatives Report :29 October 2019
Weekly Derivatives Report :29 October 2019Weekly Derivatives Report :29 October 2019
Weekly Derivatives Report :29 October 2019
 
Epicresearch daily derivatives report on 13 february 2015
Epicresearch daily derivatives report on 13 february 2015Epicresearch daily derivatives report on 13 february 2015
Epicresearch daily derivatives report on 13 february 2015
 
Daily report 14 oct
Daily report 14 octDaily report 14 oct
Daily report 14 oct
 
Weekly Derivatives Report :25 February 2019
Weekly Derivatives Report :25 February 2019Weekly Derivatives Report :25 February 2019
Weekly Derivatives Report :25 February 2019
 
Weekly Derivatives Report :23 September 2019
Weekly Derivatives Report :23 September 2019Weekly Derivatives Report :23 September 2019
Weekly Derivatives Report :23 September 2019
 
Equity Research Report 02 November 2016 Ways2Capital
Equity Research Report 02 November 2016 Ways2CapitalEquity Research Report 02 November 2016 Ways2Capital
Equity Research Report 02 November 2016 Ways2Capital
 
Equity bazaar 06.05.2016
Equity bazaar 06.05.2016Equity bazaar 06.05.2016
Equity bazaar 06.05.2016
 
Equity research report Ways2Capital 22 june 2015
Equity research report Ways2Capital 22 june 2015 Equity research report Ways2Capital 22 june 2015
Equity research report Ways2Capital 22 june 2015
 
Equity Research Report 15 May 2017 Ways2Capital
Equity Research Report 15 May 2017 Ways2CapitalEquity Research Report 15 May 2017 Ways2Capital
Equity Research Report 15 May 2017 Ways2Capital
 
stock watch: Daily Equity -Report update --15th-Feb--2019
stock watch: Daily Equity -Report update --15th-Feb--2019stock watch: Daily Equity -Report update --15th-Feb--2019
stock watch: Daily Equity -Report update --15th-Feb--2019
 
Equity Newsletter For 3-October
Equity Newsletter For 3-OctoberEquity Newsletter For 3-October
Equity Newsletter For 3-October
 
Equity Research Report 19 June 2017 Ways2Capital
Equity Research Report 19 June 2017 Ways2CapitalEquity Research Report 19 June 2017 Ways2Capital
Equity Research Report 19 June 2017 Ways2Capital
 
Daily report 20 july
Daily report 20 julyDaily report 20 july
Daily report 20 july
 

Similar to Weekly Derivatives Report :10 February 2020

Similar to Weekly Derivatives Report :10 February 2020 (20)

Weekly Derivatives Report :23 December 2019
Weekly Derivatives Report :23 December 2019Weekly Derivatives Report :23 December 2019
Weekly Derivatives Report :23 December 2019
 
Weekly Derivatives Report :19 August 2019
Weekly Derivatives Report :19 August 2019Weekly Derivatives Report :19 August 2019
Weekly Derivatives Report :19 August 2019
 
Weekly Derivatives Report :26 November 2018
Weekly Derivatives Report :26 November 2018Weekly Derivatives Report :26 November 2018
Weekly Derivatives Report :26 November 2018
 
Weekly Derivatives Report :22 October 2019
Weekly Derivatives Report :22 October 2019Weekly Derivatives Report :22 October 2019
Weekly Derivatives Report :22 October 2019
 
Weekly Derivatives Report :11 November 2019
Weekly Derivatives Report :11 November 2019Weekly Derivatives Report :11 November 2019
Weekly Derivatives Report :11 November 2019
 
Epic research's weekly derivative market report 26th september 2016
Epic research's weekly derivative market report 26th september 2016Epic research's weekly derivative market report 26th september 2016
Epic research's weekly derivative market report 26th september 2016
 
Epic research's daily derivative market report 4 dec 2015
Epic research's daily derivative market report 4 dec 2015Epic research's daily derivative market report 4 dec 2015
Epic research's daily derivative market report 4 dec 2015
 
Equity Research Report 17 October 2016 Ways2Capital
Equity Research Report 17 October 2016 Ways2CapitalEquity Research Report 17 October 2016 Ways2Capital
Equity Research Report 17 October 2016 Ways2Capital
 
Equity research report 29 february 2016 Ways2Capital
Equity research report 29 february 2016 Ways2CapitalEquity research report 29 february 2016 Ways2Capital
Equity research report 29 february 2016 Ways2Capital
 
Epic research's daily derivative market report 2nd september 2016
Epic research's daily derivative market report 2nd september 2016Epic research's daily derivative market report 2nd september 2016
Epic research's daily derivative market report 2nd september 2016
 
Special report-04-october-2018-epic-research (1)
Special report-04-october-2018-epic-research (1)Special report-04-october-2018-epic-research (1)
Special report-04-october-2018-epic-research (1)
 
Epicresearch daily derivatives market report on 24 february 2015
Epicresearch daily derivatives market report on 24 february 2015Epicresearch daily derivatives market report on 24 february 2015
Epicresearch daily derivatives market report on 24 february 2015
 
Epic research weekly derivative report 3 august 2015
Epic research weekly derivative report 3 august 2015Epic research weekly derivative report 3 august 2015
Epic research weekly derivative report 3 august 2015
 
Epic research's daily derivative market report 28th april 2016
Epic research's daily derivative market report 28th april 2016Epic research's daily derivative market report 28th april 2016
Epic research's daily derivative market report 28th april 2016
 
Epic research weekly derivative report 17 august 2015
Epic research weekly derivative report 17 august 2015Epic research weekly derivative report 17 august 2015
Epic research weekly derivative report 17 august 2015
 
Epic research's daily derivative market report 1st june 2016
Epic research's daily derivative market report 1st june 2016Epic research's daily derivative market report 1st june 2016
Epic research's daily derivative market report 1st june 2016
 
Special report-21-september-2018-epic-research
Special report-21-september-2018-epic-researchSpecial report-21-september-2018-epic-research
Special report-21-september-2018-epic-research
 
Epic research daily derivative report 22 july 2015
Epic research daily derivative report 22 july 2015Epic research daily derivative report 22 july 2015
Epic research daily derivative report 22 july 2015
 
Epic research's daily derivative market report 14th june 2016
Epic research's daily derivative market report 14th june 2016Epic research's daily derivative market report 14th june 2016
Epic research's daily derivative market report 14th june 2016
 
Epic research weekly derivative report 24 november 2014
Epic research weekly  derivative report 24 november 2014Epic research weekly  derivative report 24 november 2014
Epic research weekly derivative report 24 november 2014
 

More from Axis Direct

More from Axis Direct (20)

Daily Technical Report:30 March 2020
Daily Technical Report:30 March 2020Daily Technical Report:30 March 2020
Daily Technical Report:30 March 2020
 
Daily Derivatives Report:30 March 2020
Daily Derivatives Report:30 March 2020Daily Derivatives Report:30 March 2020
Daily Derivatives Report:30 March 2020
 
Daily Derivatives Report:27 March 2020
Daily Derivatives Report:27 March 2020Daily Derivatives Report:27 March 2020
Daily Derivatives Report:27 March 2020
 
Daily Technical Report:27 March 2020
Daily Technical Report:27 March 2020Daily Technical Report:27 March 2020
Daily Technical Report:27 March 2020
 
Daily Derivatives Report:26 March 2020
Daily Derivatives Report:26 March 2020Daily Derivatives Report:26 March 2020
Daily Derivatives Report:26 March 2020
 
Daily Technical Report:26 March 2020
Daily Technical Report:26 March 2020Daily Technical Report:26 March 2020
Daily Technical Report:26 March 2020
 
Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020
 
Daily Technical Report:25 March 2020
Daily Technical Report:25 March 2020Daily Technical Report:25 March 2020
Daily Technical Report:25 March 2020
 
Daily Derivatives Report:24 March 2020
Daily Derivatives Report:24 March 2020Daily Derivatives Report:24 March 2020
Daily Derivatives Report:24 March 2020
 
Daily Technical Report:24 March 2020
Daily Technical Report:24 March 2020Daily Technical Report:24 March 2020
Daily Technical Report:24 March 2020
 
Daily Technical Report:23 March 2020
Daily Technical Report:23 March 2020Daily Technical Report:23 March 2020
Daily Technical Report:23 March 2020
 
Daily Derivatives Report:20 March 2020
Daily Derivatives Report:20 March 2020Daily Derivatives Report:20 March 2020
Daily Derivatives Report:20 March 2020
 
Daily Technical Report:20 March 2020
Daily Technical Report:20 March 2020Daily Technical Report:20 March 2020
Daily Technical Report:20 March 2020
 
Daily Derivatives Report:19 March 2020
Daily Derivatives Report:19 March 2020Daily Derivatives Report:19 March 2020
Daily Derivatives Report:19 March 2020
 
Daily Technical Report:19 March 2020
Daily Technical Report:19 March 2020Daily Technical Report:19 March 2020
Daily Technical Report:19 March 2020
 
Daily Technical Report:18 March 2020
Daily Technical Report:18 March 2020Daily Technical Report:18 March 2020
Daily Technical Report:18 March 2020
 
Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020
 
Daily Technical Report:17 March 2020
Daily Technical Report:17 March 2020Daily Technical Report:17 March 2020
Daily Technical Report:17 March 2020
 
Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020
 
Daily Derivatives Report:13 March 2020
Daily Derivatives Report:13 March 2020Daily Derivatives Report:13 March 2020
Daily Derivatives Report:13 March 2020
 

Recently uploaded

💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
Cara Menggugurkan Kandungan 087776558899
 

Recently uploaded (8)

9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos
9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos
9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos
 
KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...
KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...
KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...
 
Namakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRL
Namakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRLNamakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRL
Namakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRL
 
Prince Armahs(Tinky) Brochure, for Funeral service
Prince Armahs(Tinky) Brochure, for Funeral servicePrince Armahs(Tinky) Brochure, for Funeral service
Prince Armahs(Tinky) Brochure, for Funeral service
 
Hosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRL
Hosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRLHosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRL
Hosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRL
 
BERHAMPUR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...
BERHAMPUR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...BERHAMPUR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...
BERHAMPUR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...
 
BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...
BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...
BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...
 
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
 

Weekly Derivatives Report :10 February 2020

  • 1. 8 February 2020 For private circulation only DAILY DERIVATIVE REPORT 10 FEB 2020 Nifty Futures View Volatility BankNifty Future View Nifty Active Futures 12095.9 India VIX Index 13.74 BankNifty Active Futures 31240.00 Nifty Active Futures OI 13771200 Nifty ATM Call IV 8.6 BankNifty Active Futures OI 11,57,580 Change in OI 21450 Nifty ATM Put IV 14.74 Change in OI 36160 Premium / Discount -2.45 PCR Index Options 1.40 Premium / Discount 38.00 Inference Short Build up PCR F&O Total 0.92 Inference Short Build up NNiiffttyy OOppttiioonnss OOII DDiissttrriibbuuttiioonn HIGHLIGHTS: Nifty futures closed at 12095.9 on a negative note with 0.16% increase in open interest indicating Short Build Up. Nifty Futures closed at a discount of -2 points compared to previous day discount of -2 points. BankNifty closed at 31240 on a negative note with 3.22% increase in open interest indication Short Build Up. BankNifty Futures closed at a premium of 38 points compared to the previous day premium of 29 points. FII's were Sellers in Index Futures to the tune of 428 crores and were Buyers in Index Options to the tune of 1025 crores, Stock Futures were Buyers to the tune of 273 crores. FII's were Net Buyers in derivative segment to the tune of 869 crores. India VIX index is at 13.74. Nifty ATM call option IV is currently at 8.60 whereas Nifty ATM put option IV is quoting at 14.74. NNiiffttyy OOppttiioonnss --CChhaannggee iinn OOII Index options PCR is at 1.40 and F&O Total PCR is at 0.92. Among stock futures IDEA ,DIVISLAB ,APOLLOHOSP & SRF have witnessed long build up and may show strength in coming session. Stock which witnessed short build up are MRF ,GODREJCP ,KOTAKBANK & DLF and may remain weak in coming session. Nifty Put options OI distribution shows that 12000 has highest OI concentration followed by 11500 & 11600 which may act as support for current expiry. Nifty Call strike 12500 followed by 12400 witnessed significant OI concentration and may act as resistance for current expiry. SSEECCUURRIITTIIEESS IINN BBAANN PPEERRIIOODD:: __________________________________________________________________________________________________________________ SSttoocckk FFuuttuurreess -- LLoonngg BBuuiilldd ____________________________________________________________________________________________________________ SSttoocckk FFuuttuurreess -- SShhoorrtt BBuuiilldd UUpp Symbol Fut Price % Chg Open Interest % Chg IDEA 5.30 1.92% 473536000.00 9.37% DIVISLAB 2074.70 2.25% 1770000.00 8.80% APOLLOHOSP 1669.45 1.26% 1811500.00 8.47% SRF 4098.30 2.23% 896250.00 6.32% Symbol Fut Price % Chg Open Interest % Chg MRF 70962.80 -1.22% 21570.00 9.55% GODREJCP 649.65 -0.76% 6480000.00 8.36% KOTAKBANK 1660.20 -1.21% 8858800.00 6.95% DLF 235.65 -4.27% 34409100.00 6.37%
  • 2. WEEKLY DERIVATIVE REPORT Week ended 7th Feb 2020 NNIIFFTTYY HHIIGGHHLLIIGGHHTTSS::  Nifty Futures has increased by 3.78% to close at 12,095 from previous week close of 11,655.  Nifty annualized volatility index India Vix has decreased to 13.75% from 16.83% down by 18.34%.  The total open interest (OI) in the Nifty stood at Rs 8,345cr.Where as stock futures OI is at 47,148cr.  The open interest position of FII in Index Futures is at Rs 14,616Cr and in Stock futures is at Rs 104,140Cr. Nifty PCR OI  PCR OI has made a high of 1.48 & low of 0.86 and closed on weekly basis at 1.40 levels.  PCR OI currently is at 1.40 levels which is well above the median line indicating that we might see some cautiousness in Nifty from higher levels. OOppeenn IInntteerreesstt AAnnaallyyssiiss  Options Built up Shows that for now nifty has strong support at 12,000 followed by 11,500 and resistance at 12,400 levels followed by 12,500.  12,400 & 12,500 strike call and 12,200 put followed by 11,500 put has highest open interest concentration which suggests that Nifty is likely to trade between this levels. CChhaannggee iinn OOppeenn IInntteerreesstt  This week major addition was seen on the Put front with 11,900 and 11,600 strikes adding 10.71 and 13.00 lakh in OI respectively.  On the Call front we have seen addition at 12,400 strike with increase in OI of 7.34 lakh shares and an increase of 8.35 lakh shares at 12,500 strike. 0.80 1.00 1.20 1.40 1.60 1.80 2.00 3.00 4.00 5.00 6.00 7.00 8.00 28-Jan 29-Jan 30-Jan 31-Jan 1-Feb 3-Feb 4-Feb 5-Feb 6-Feb 7-Feb PUTCALLRATIO OIincr. Call OI Put OI 0 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 11500 11600 11700 11800 11900 12000 12100 12200 12300 12400 12500 12600 12700 OpenInterest Open Interest Put OI Call OI -1,000,000 -500,000 0 500,000 1,000,000 1,500,000 11500 11600 11700 11800 11900 12000 12100 12200 12300 12400 12500 12600 12700 OpenInterest Change in Open Interest Call OI Put OI
  • 3. WEEKLY DERIVATIVE REPORT VVoollaattiilliittyy AAnnaallyyssiiss  IV differential between call and put has increased from last week level, which implies that nifty is most likely to trade cautious from the current levels, however the bias might be positive.  Call IV’s currently at 11.53%, while Put IV’s are at 13.57%.  Implied Volatility of option for the current series is at 12.54% and has seen downward trajectory in this week. WWeeeekkllyy PPaarrttiicciippaanntt WWiissee OOppeenn IInntteerreesstt Participant FUT IDX Long (contracts) Net Chg FUT IDX Short (contracts) Net Chg Client 182,190 51,721 81,128 15,911 DII 29,224 -11,225 18,451 4,995 FII 29,974 7,408 142,484 18,555 Pro 17,319 -4,064 16,644 4,379 Participant FUT STK Long (contracts) Net Chg FUT STK Short (contracts) Net Chg Client 792,088 16,456 235,916 82,778 DII 37,225 12,869 1,043,075 -11,611 FII 976,653 80,587 605,927 33,812 Pro 172,525 23,314 93,573 28,247 FFIIII IInnddeexx FFuuttuurreess  FII activity in the index futures had been mostly on the Buy side during this week.  FII have been net Buyer in Index future to the tune of 557 crore during this week. FFIIII SSttoocckk FFuuttuurreess  FII activity in Stock futures had been on the Buy side during the last week.  This week FII have been net Buyers in stock future segment to the tune 3812 crore. 8.50 10.50 12.50 14.50 16.50 18.50 20.50 22.50 28-Jan- 20 29-Jan- 20 30-Jan- 20 31-Jan- 20 1-Feb- 20 3-Feb- 20 4-Feb- 20 5-Feb- 20 6-Feb- 20 7-Feb- 20 Implied volatility(IV) IV Call Iv Put Historic volatility 160,000 165,000 170,000 175,000 180,000 185,000 190,000 03-Feb 04-Feb 05-Feb 06-Feb 07-Feb -600 -400 -200 0 200 400 600 800 InCrores NET AMT OI IN CONTRACT 1,510,000 1,520,000 1,530,000 1,540,000 1,550,000 1,560,000 1,570,000 1,580,000 1,590,000 03-Feb 04-Feb 05-Feb 06-Feb 07-Feb 0 200 400 600 800 1,000 1,200 1,400 1,600 1,800 InCrores NET AMT OI IN CONTRACT
  • 4. WEEKLY DERIVATIVE REPORT SSeeccttoorr WWiissee OOppeenn IInntteerreesstt AAnndd PPrriiccee DDaattaa WWeeeekkllyy PPrriiccee CChhaannggee WWeeeekkllyy OOII CChhaannggee WWeeeekkllyy PPCCRR CChhaannggee WWeeeekkllyy OOppeenn IInntteerreesstt GGaaiinneerr WWeeeekkllyy OOppeenn IInntteerreesstt LLoosseerr Script ID Price % Chg OI Futures % Chg MANAPPURAM 167.6 -11.09% 35076000 90.98% AMBUJACEM 210.5 2.38% 31827500 76.82% HEROMOTOCO 2383.05 -2.97% 3442600 70.54% APOLLOTYRE 164.7 -1.26% 14313000 44.27% CHOLAFIN 340.7 3.97% 6497500 42.49% Script ID Price % Chg OI Futures % Chg MFSL 481.35 -5.05% 5153200 -40.26% IOC 117.25 4.87% 54520000 -29.37% JUBLFOOD 1905.35 1.32% 2483500 -18.13% TORNTPHARM 2025.65 4.98% 341500 -17.21% RBLBANK 339.35 6.43% 14268000 -14.97% WWeeeekkllyy PPrriiccee GGaaiinneerr WWeeeekkllyy PPrriiccee LLoosseerr Script ID Price % Chg OI Futures % Chg SRTRANSFIN 1210.45 17.92% 5176200 8.69% AUROPHARMA 546.75 13.57% 14781000 -2.39% L&TFH 132 12.87% 28806400 -8.52% JINDALSTEL 198.65 12.58% 33265000 6.50% JSWSTEEL 279.85 11.07% 62157500 7.56% Script ID Price % Chg OI Futures % Chg MANAPPURAM 167.6 -11.09% 35076000 90.98% ITC 214.2 -9.41% 141525600 10.99% DLF 235.65 -9.37% 34409100 11.21% EXIDEIND 182.4 -7.62% 11327400 9.23% ZEEL 250.5 -7.12% 29557900 22.99% 1.18% 6.00% 0.79% -9.23% 1.34% 6.86% 1.33% 0.73% 2.91% -5.13% 0.88% 3.44% 4.47% 3.32% -1.69% 6.36% 2.44% 2.02% -1.39% Wkly Price change Textile Fertilisers Oil_Gas Cement Capital_Good s Media FMCG Pharma Automobile Infrastructure Finance Others Power Metals Technology Realty Banking Telecom Index 22.09% 12.80% 4.58% 0.80% 7.67% 14.41% 18.94% 9.79% 9.48% 1.25% 12.30% 5.82% 10.24% 13.59% 4.01% 15.35% 2.61% 17.17% 19.71% Wkly OI change Textile Fertilisers Oil_Gas Cement Capital_Good s Media FMCG Pharma Automobile Infrastructure Finance Others Power Metals Technology Realty Banking Telecom Index 1.11% 0.33% 1.76% 1.54% 1.32% 2.27% 1.48% 1.30% 1.72% 0.98% 1.41% 1.52% 1.17% 0.45% 1.77% 6.87% 1.87% 0.30% 0.66% Wkly Roll Over change Textile Fertilisers Oil_Gas Cement Capital_Good s Media FMCG Pharma Automobile Infrastructure Finance Others Power Metals Technology Realty Banking Telecom Index
  • 5. WEEKLY DERIVATIVE REPORT SSttoocckk wwiissee OOppeenn IInntteerreesstt DDiissttrriibbuuttiioonn iinn BBaannkkiinngg SSeeccttoorr BBaannkk NNiiffttyy OOppeenn IInntteerreesstt ffoorr PPSSUU BBaannkkss VV//ss PPrriivvaattee BBaannkkss BBaannkk NNiiffttyy SSttrriikkee wwiissee ooppeenn iinntteerreesstt ddiissttrriibbuuttiioonn RBLBANK, HDFCBANK and ICICIBANK can see some POSITIVE move in this week. Bank Nifty has a very strong support at 31,000, as 31,000 PE strike is having highest OI concentration followed by 30,500 and on the Call front 32,000 CE strike has highest OI concentration indicating strong resistance level followed by 31,500. AXISBANK BANKBARODA CANBK FEDERALBNK HDFCBANK ICICIBANK IDFCFIRSTB INDUSINDBKKOTAKBANK PNB, 11% RBLBANK SBIN, 10% YESBANK 29% 71% Open Interest Psu Bank Private Bank 0 50,000 100,000 150,000 200,000 250,000 300,000 30200 30300 30400 30500 30600 30700 30800 30900 31000 31100 31200 31300 31400 31500 31600 31700 31800 31900 32000 32100 32200 OpenInterest Open Interest Call OI Put OI
  • 6. WEEKLY DERIVATIVE REPORT Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations). 1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com. 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12- month period. Research Team Sr. No Name Designation E-mail 1 Rajesh Palviya Technical & DerivativeAnalyst - (Head) rajesh.palviya@axissecurities.in 2 Vaishnavi Jagtap Technical Analyst vaishnavi.jagtap@axissecurities.in 3 Hemang Gor Derivative Analyst hemang.gor@axissecurities.in 4 Rahil.vora Derivative Analyst Rahil.vora@axissecurities.in 5 Hiren Trivedi Research Associate hiren.trivedi@axissecurities.in 6 Kiran Gawle Associate kiran.gawle@axissecurities.in 5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for the subject company. 6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have: i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report.
  • 7. WEEKLY DERIVATIVE REPORT Disclaimer: Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited. Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI – INZ000161633, ARN No. 64610, CDSL-IN-DP-CDSL-693-2013, SEBI- Research Analyst Reg. No. INH 000000297, SEBI Portfolio Manager Reg. No.- INP000000654, Main/Dealing off.- Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. – 18002100808, Reg. off.- Axis House, 8th Floor, Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai – 400 025.Compliance Officer: Anand Shaha, E-Mail ID: compliance.officer@axisdirect.in,Tel No: 022-42671582.